Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vornorexant for insomnia in adults with type 2 diabetes mellitus
jRCTs061260025Recruiting
- Sponsor
- Taisho Pharmaceutical
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of vornorexant in Insomnia, sponsored by Taisho Pharmaceutical. Started Jul 2026; status: recruiting.
02
Drugs
vornorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on jRCTs061260025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061260025.